A Randomized Controlled Study of the NEURESCUE Device as an Adjunct to Advanced Cardiac Life Support

NANot yet recruitingINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

May 31, 2025

Primary Completion Date

January 31, 2027

Study Completion Date

March 31, 2027

Conditions
Cardiac Arrest (CA)Cardiopulmonary Arrest
Interventions
PROCEDURE

Advanced Cardiac Life Support (ACLS)

Standard of care Advanced Cardiac Life Support (ACLS) consists of cardiopulmonary resuscitation (CPR), airway management, ventilation and defibrillation.

DEVICE

Aortic balloon occlusion (ABO)

"Aortic balloon occlusion (ABO) is a technique that diverts blood flow towards the coronary and cerebral circulation. ABO is investigated as an adjunct to the treatment of cardiac arrest.~In this study ABO is performed using the NEURESCUE Catheter, which is inserted through an introducer in the femoral artery, and thereby inserted into the aorta during uninterrupted Advanced Cardiac Life Support (ACLS). The balloon is then temporarily inflated as an adjunct to the treatment of cardiac arrest."

Trial Locations (2)

12203

Charité - Universitätsklinikum Berlin, Berlin

69120

University Hospital Heidelberg, Heidelberg

Sponsors

Lead Sponsor

All Listed Sponsors
lead

neurescue

INDUSTRY

NCT06793033 - A Randomized Controlled Study of the NEURESCUE Device as an Adjunct to Advanced Cardiac Life Support | Biotech Hunter | Biotech Hunter